Skip to main content
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. logo

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings

Ticker · 688238 ISIN · CNE1000059N9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2025-11-04 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688238

About SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD.

https://www.obio-tech.com/

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.

Recent filings

Filing Released Lang Actions
2025年第四次临时股东会会议资料
Board/Management Information Classification · 95% confidence The document is titled as "2025 年第四次临时股东会 会议资料" which translates to "2025 Fourth Extraordinary General Meeting (EGM) Meeting Materials." It contains detailed meeting instructions, agenda, and proposals related to the election and resignation of board members. The content focuses on board member changes and the procedures for the shareholders' meeting, including voting and legal compliance. There is no financial data or earnings information, nor is it a report or announcement of financial results. The document is clearly meeting materials for a shareholders' meeting, specifically an extraordinary general meeting, and relates to board/management changes. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is over 5,000 characters and contains substantive content, so it is not a mere announcement or notice (RPA or RNS).
2025-11-04 Chinese
关于召开2025年三季度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement from a company about the scheduling and details of a quarterly earnings explanation meeting (业绩说明会) for the third quarter of 2025. It mentions the date, time, location, participants, and how investors can participate and ask questions. It references the previously disclosed 2025 third quarter report but does not contain the report itself or detailed financial data. The document is short (1550 characters) and serves as a notice for an upcoming investor presentation event rather than the presentation or report itself. Therefore, it fits best as an Investor Presentation (IP) announcement or related material. Given the detailed description of the meeting and interaction with investors, the classification as Investor Presentation (IP) is appropriate with high confidence.
2025-10-27 Chinese
关于召开2025年第四次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about convening the 2025 fourth extraordinary shareholders meeting (临时股东会) of 和元生物技术（上海）股份有限公司. It includes information about the meeting date, voting methods, agenda items (such as election of directors), voting procedures, and instructions for shareholders. It also contains attachments like proxy forms and explanations of cumulative voting. There is no financial data or results reported, nor is it a transcript or presentation. It is not an announcement of voting results but a notice to convene the meeting and provide materials for shareholders to vote. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings.
2025-10-27 Chinese
科创板上市公司独立董事候选人声明与承诺
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate for a listed company on the Science and Technology Innovation Board (科创板). It details the candidate's qualifications, compliance with regulatory requirements, independence criteria, and commitments to fulfill the duties of an independent director. There is no financial data, no report or announcement of financial results, no voting results, no management changes, and no regulatory filing of a report. This document is a formal statement related to board/management information, specifically concerning the nomination and qualifications of a board member. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2025-10-27 Chinese
关于公司董事辞职暨补选董事并调整董事会专门委员会委员的公告
Board/Management Information Classification · 95% confidence The document is an official announcement from a company regarding resignations and appointments of board members and adjustments to board committees. It includes detailed information about the directors leaving and joining, their qualifications, and the impact on the board's operation. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes in the company's board of directors and management structure. Therefore, it fits the category of Board/Management Information (MANG). The document length is about 4200 characters, which is typical for such announcements. Hence, the classification is MANG with high confidence.
2025-10-27 Chinese
董事会提名委员会关于独立董事候选人的审核意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from the Board Nomination Committee regarding the qualification review of an independent director candidate. It references company law, securities law, and company bylaws, and concludes with a nomination proposal to the board. This is an announcement related to board/management changes, specifically about the nomination of a new independent director. It is not a full report, financial statement, or regulatory filing. Therefore, it fits best under Board/Management Information (MANG). The document length and content confirm it is not a report or announcement of a report publication.
2025-10-27 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.